title: Neurofibromatosis type 1 and infantile spasms.
abstract: BACKGROUND
  There is no agreement on the prevalence, natural history and outcome of infantile spasms (IS) in neurofibromatosis type 1 (NF1). By contrast, its prevalence and outcome are well characterised in the setting of other neurocutaneous disorders (e.g. tuberous sclerosis).
  
  
  METHODS
  The aim of the present study was to try to establish a genotype-phenotype correlation in IS in the setting of NF1. A retrospective (years 1990-2000) and prospective (years 2000-2006) study in three paediatric centres in Italy were taken as referral populations for: (1) children with NF1 and (2) neurological problems in childhood.
  
  
  RESULTS
  Ten NF1 patients have had IS. The calculated population-based: (1) prevalence of IS in NF1 (0.76%) was higher than the reported frequency of IS in the general population (0.02-0.05%) and (2) frequency of NF1 in the IS series in two out of three centres (0.62-0.90%) was lower than the estimated frequencies in the literature (1.5-3.0%). Patients had psychomotor delay preceding the spasms (50%), symmetrical spasms (50%), typical (80%) and modified (20%) hypsarrhythmia and foci of spikes and waves and a good response to corticosteroid treatment (50%). Outcome was good in 30%. Imaging revealed high-signal foci in atypical locations (sub-cortical and central brain regions). Deoxyribonucleic acid analysis revealed three novel NF1 gene mutations without genotype-phenotype correlation.
  
  
  CONCLUSIONS
  Even though the combination of IS and NF1 does not seem to be coincidental, it is certainly an unusual event in NF1--rarer than in other neurocutaneous disorders. Spasms in NF1 are not associated with specific genetic defects.
authors.affiliation: Institute of Neurological Science, National Research Council, Viale R. Margherita, 6, Catania, 95124, Italy. m.ruggieri@isn.cnr.it
authors.forename: Martino
authors.initials: M
authors.lastname: Ruggieri
authors.forename: Paola
authors.initials: P
authors.lastname: Iannetti
authors.forename: Maurizio
authors.initials: M
authors.lastname: Clementi
authors.forename: Agata
authors.initials: A
authors.lastname: Polizzi
authors.forename: Gemma
authors.initials: G
authors.lastname: Incorpora
authors.forename: Alberto
authors.initials: A
authors.lastname: Spalice
authors.forename: Piero
authors.initials: P
authors.lastname: Pavone
authors.forename: Andrea Domenico
authors.initials: AD
authors.lastname: Praticò
authors.forename: Maurizio
authors.initials: M
authors.lastname: Elia
authors.forename: Anna Lia
authors.initials: AL
authors.lastname: Gabriele
authors.forename: Romano
authors.initials: R
authors.lastname: Tenconi
authors.forename: Lorenzo
authors.initials: L
authors.lastname: Pavone
mesh_terms: D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D005260:Female; D005838:Genotype; D006801:Humans; D007223:Infant; D007558:Italy / Q000453:epidemiology; D008297:Male; D009154:Mutation; D009456:Neurofibromatosis 1 / Q000150:complications* / Q000453:epidemiology / Q000235:genetics; D025542:Neurofibromin 1 / Q000235:genetics; D010641:Phenotype; D015995:Prevalence; D011446:Prospective Studies; D012189:Retrospective Studies; D013036:Spasms, Infantile / Q000453:epidemiology / Q000209:etiology*
chemical_list: D025542:Neurofibromin 1